Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stock market
Biotech
ReNeuron leaving AIM exchange after missing fundraising goal
The stem cell biotech is letting go of its listing after money troubles persuaded it to free itself from the costs and obligations of the exchange.
Nick Paul Taylor
Aug 30, 2024 10:30am
Why do so many biotechs face being kicked off the Nasdaq?
Mar 14, 2023 9:55am
BridgeBio fears biotech markets may stay 'pretty bad' until 2024
May 24, 2022 8:37am
Ginkgo bowled over as short seller dubs it 'a hoax for the ages'
Oct 6, 2021 3:03pm
Cassava CEO blames short sellers for data woes
Sep 3, 2021 8:28am
BioCryst scraps $200M offering after seeing share price slide
Aug 11, 2021 7:35am
